Thus, the MTT and colony formation assays yielded similar results indicating that expression of WT-GSK-3β enhanced resistance to a GSK-3 inhibitor, the type-II diabetes drug metformin, and the nutraceutical berberine. Here, GSK3B is linked to type 2 diabetes mellitus.